| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |